Michael ToVinh

Michael ToVinh

Auto-generated profile, based on publicly available information

Michael ToVinh

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2021 in Immunity
Verified
Journal Article
Closed access
BKBenjamin Krämer
Benjamin Krämer
RKRainer Knoll
Rainer Knoll
LBLorenzo Bonaguro
Lorenzo Bonaguro
MTMichael ToVinh
Michael ToVinh
JRJan Raabe
Jan Raabe
JNJacob Nattermann
Jacob Nattermann

1 January 2023 in Cell Reports
Verified
Journal Article
Open access
BKBenjamin Kraemer
Benjamin Kraemer
ANAnsel P. Nalin
Ansel P. Nalin
FMFeiyang Ma
Feiyang Ma
SESarah Eickhoff
Sarah Eickhoff
PLPhilipp Lutz
Philipp Lutz
JNJacob Nattermann
Jacob Nattermann
Group 1 innate lymphoid cells (ILCs) comprise a heterogeneous family of cytotoxic natural killer (NK) cells and ILC1s. We identify a population of "liver-type" ILC1s with transcriptional, phenotypic, and functional features distinct from those of conventional and liver-resident NK cells as well as from other previously described human ILC1 subsets. LT-ILC1s are CD49a+CD94+CD200R1+, express the transcription factor T-BET, and do not express the activating receptor NKp80 or the transcription factor EOMES. Similar to NK cells, liver-type ILC1s produce IFN-γ, TNF-α, and GM-CSF; however, liver-type ILC1s also produce IL-2 and lack perforin and granzyme-B. Liver-type ILC1s are expanded in cirrhotic liver tissues, and they can be produced from blood-derived ILC precursors in vitro in the presence of TGF-β1 and liver sinusoidal endothelial cells. Cells with similar signature and function can also be found in tonsil and intestinal tissues. Collectively, our study identifies and classifies a population of human cross-tissue ILC1s.

10 April 2023 in Hepatology
Verified
Journal Article
Closed access
JRJan Raabe
Jan Raabe
KKKim M. Kaiser
Kim M. Kaiser
MTMichael ToVinh
Michael ToVinh
CFClaudia Finnemann
Claudia Finnemann
PLPhilipp Lutz
Philipp Lutz
JNJacob Nattermann
Jacob Nattermann
Background and Aims: Human innate lymphoid cells (ILCs) are critically involved in the modulation of homeostatic and inflammatory processes in various tissues. However, only little is known about the composition of the intrahepatic ILC pool and its potential role in chronic liver disease. Here, we performed a detailed characterization of intrahepatic ILCs in both healthy and fibrotic livers. Approach and Results: A total of 50 livers (nonfibrotic = 22, and fibrotic = 29) were analyzed and compared with colon and tonsil tissue (each N = 14) and peripheral blood (N = 32). Human intrahepatic ILCs were characterized ex vivo and on stimulation using flow cytometry and single-cell RNA sequencing. ILC differentiation and plasticity were analyzed by both bulk and clonal expansion experiments. Finally, the effects of ILC-derived cytokines on primary human HSteCs were studied. Unexpectedly, we found that an “unconventional” ILC3-like cell represented the major IL-13-producing liver ILC subset. IL-13+ ILC3-like cells were specifically enriched in the human liver, and increased frequencies of this cell type were found in fibrotic livers. ILC3-derived IL-13 production induced upregulation of proinflammatory genes in HSteCs, indicating a potential role in the regulation of hepatic fibrogenesis. Finally, we identified KLRG1-expressing ILC precursors as the potential progenitor of hepatic IL-13+ ILC3-like cells. Conclusions: We identified a formerly undescribed subset of IL-13–producing ILC3-like cells that is enriched in the human liver and may be involved in the modulation of chronic liver disease.

21 March 2022 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MTMichael ToVinh
Michael ToVinh
GHGregor Hörr
Gregor Hörr
KDKristiyana Dobrikova
Kristiyana Dobrikova
CGChristina Gotter
Christina Gotter
CRClemens Rommel
Clemens Rommel
JNJacob Nattermann
Jacob Nattermann
Human immunodeficiency virus (HIV) infection is associated with impaired natural killer (NK) cell activity, which is only incompletely restored under antiretroviral therapy. Analyzing the bioenergetics profiles of oxygen consumption, we observed that several parameters were significantly reduced in HIV+ NK cells, indicating a mitochondrial defect. Accordingly, we found HIV+ CD56bright NK cells to display a decreased mitochondrial membrane potential and mitochondrial mass. Both parameters were positively correlated with interferon gamma (IFN-γ) production of NK cells. Finally, we demonstrated that stimulation of HIV+ NK cells with MitoTEMPO, a mitochondria-targeting antioxidant, significantly improved IFN-γ production. We identified mitochondrial dysfunction as a mechanism that contributes to impaired NK cell function.

15 December 2022 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MTMichael ToVinh
Michael ToVinh
GHGregor Hörr
Gregor Hörr
CHChristoph Hoffmeister
Christoph Hoffmeister
KDKristiyana Dobrikova
Kristiyana Dobrikova
CGChristina Gotter
Christina Gotter
JNJacob Nattermann
Jacob Nattermann
The mechanisms involved in HIV-associated natural killer (NK) cell impairment are still incompletely understood. We observed HIV infection to be associated with increased plasma levels of IFABP, a marker for gut epithelial barrier dysfunction, and LBP, a marker for microbial translocation. Both IFABP and LBP plasma concentrations were inversely correlated with NK cell interferon-γ production, suggesting microbial translocation to modulate NK cell functions. Accordingly, we found lipopolysaccharide to have an indirect inhibitory effect on NK cells via triggering monocytes’ transforming growth factor-β production. Taken together, our data suggest increased microbial translocation to be involved in HIV-associated NK cell dysfunction.